Fig. 1
From: Upregulation of SLC2A3 gene and prognosis in colorectal carcinoma: analysis of TCGA data
Kaplan-Meier survival analysis of colorectal cancer patients stratified by SLC2A3 expression levels (Discovery set). Overall survival (a) and disease-free survival (b) curve of patients in discovery set with high versus low SLC2A3 expression levels. P-values for significance of difference between high and low expression were calculated using the log-rank test
